Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Apremilast showed mixed results for treating severe alopecia areata.

A woman's hair loss was probably caused by the antifungal drug anidulafungin.

Biosimilars lower costs but don't significantly improve access.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Teriflunomide can cause hair thinning.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Canakinumab's effect on COVID-19 outcomes is unclear.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Tofacitinib significantly improved skin and hair conditions without side effects.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Finasteride was more effective than hydroxychloroquine in treating frontal fibrosing alopecia.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.